Clinical trial
An Eighteen Month Efficacy and Safety Study in Obese Patients…
NCT00131430 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00131430 |
|---|---|
| Title | An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED) |
| Official title | An 18-Month Study to Assess the Safety, Tolerability, and Efficacy of MK0364 in Obese Patients |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Obesity and Obesity-related Medical Conditions |
| Intervention type | Drug |
| Interventions | taranabant |
| Enrollment | 500 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Aug 18, 2005 |
| Last update posted | Jun 7, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: